JP2022554392A5 - - Google Patents

Info

Publication number
JP2022554392A5
JP2022554392A5 JP2022526331A JP2022526331A JP2022554392A5 JP 2022554392 A5 JP2022554392 A5 JP 2022554392A5 JP 2022526331 A JP2022526331 A JP 2022526331A JP 2022526331 A JP2022526331 A JP 2022526331A JP 2022554392 A5 JP2022554392 A5 JP 2022554392A5
Authority
JP
Japan
Prior art keywords
compound according
substituted
compound
alkyl
cyano
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022526331A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022554392A (ja
JP7787811B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/059228 external-priority patent/WO2021092264A1/en
Publication of JP2022554392A publication Critical patent/JP2022554392A/ja
Publication of JP2022554392A5 publication Critical patent/JP2022554392A5/ja
Application granted granted Critical
Publication of JP7787811B2 publication Critical patent/JP7787811B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022526331A 2019-11-05 2020-11-05 MrgprX2アンタゴニストおよびその使用 Active JP7787811B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201962931186P 2019-11-05 2019-11-05
US62/931,186 2019-11-05
US201962931576P 2019-11-06 2019-11-06
US62/931,576 2019-11-06
US202063046481P 2020-06-30 2020-06-30
US63/046,481 2020-06-30
PCT/US2020/059228 WO2021092264A1 (en) 2019-11-05 2020-11-05 MrgprX2 ANTAGONISTS AND USES THEREOF

Publications (3)

Publication Number Publication Date
JP2022554392A JP2022554392A (ja) 2022-12-28
JP2022554392A5 true JP2022554392A5 (cg-RX-API-DMAC7.html) 2023-10-31
JP7787811B2 JP7787811B2 (ja) 2025-12-19

Family

ID=73740488

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022526331A Active JP7787811B2 (ja) 2019-11-05 2020-11-05 MrgprX2アンタゴニストおよびその使用

Country Status (8)

Country Link
US (1) US20230002336A1 (cg-RX-API-DMAC7.html)
EP (1) EP4055011A1 (cg-RX-API-DMAC7.html)
JP (1) JP7787811B2 (cg-RX-API-DMAC7.html)
CN (1) CN114728919B (cg-RX-API-DMAC7.html)
AU (1) AU2020380926B2 (cg-RX-API-DMAC7.html)
CA (1) CA3159633A1 (cg-RX-API-DMAC7.html)
IL (1) IL292693B1 (cg-RX-API-DMAC7.html)
WO (1) WO2021092264A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115850094B (zh) * 2022-09-07 2025-02-11 北华航天工业学院 一种利用1,2-环氧丁烷合成β-氨基醇的方法
WO2025002360A1 (zh) * 2023-06-30 2025-01-02 北京普祺医药科技股份有限公司 一种mrgprx2拮抗剂、药物组合物以及其用途
US20250084063A1 (en) 2023-08-18 2025-03-13 Incyte Corporation Bicyclic heterocycles as mrgprx2 antagonists
WO2025160430A1 (en) 2024-01-25 2025-07-31 Incyte Corporation Bicyclic heterocycles as mrgprx2 antagonists
WO2025163462A1 (ko) * 2024-02-02 2025-08-07 삼진제약주식회사 헤테로고리를 갖는 mrgprx2((mas-related g-protein coupled receptor member x2) 길항제 유도체와 이의 용도
WO2025222076A1 (en) 2024-04-19 2025-10-23 Kyorin Pharmaceutical Co., Ltd. 1h-pyrrolo[2,3-b]pyridine derivatives as mrgprx2 antagonists for the treatment of inflammatory diseases
WO2025222040A1 (en) 2024-04-19 2025-10-23 Escient Pharmaceuticals, Inc. Mrgprx2 modulators for use in treating mrgprx2 dependent conditions in subjects with low ige
US12630562B2 (en) 2024-08-07 2026-05-19 Arcus Biosciences, Inc. Piperidylurea compounds and methods of use thereof

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4152442A (en) * 1975-06-05 1979-05-01 Lilly Industries Limited Certain acylamino-oxa (or thia) diazoles in treatment of hypersensitivity conditions
US4328245A (en) 1981-02-13 1982-05-04 Syntex (U.S.A.) Inc. Carbonate diester solutions of PGE-type compounds
US4410545A (en) 1981-02-13 1983-10-18 Syntex (U.S.A.) Inc. Carbonate diester solutions of PGE-type compounds
US4409239A (en) 1982-01-21 1983-10-11 Syntex (U.S.A.) Inc. Propylene glycol diester solutions of PGE-type compounds
EP0084665B1 (de) * 1982-01-22 1986-08-13 BASF Aktiengesellschaft Thiadiazolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Bekämpfung unerwünschten Pflanzenwuchses
US5052558A (en) 1987-12-23 1991-10-01 Entravision, Inc. Packaged pharmaceutical product
US5033252A (en) 1987-12-23 1991-07-23 Entravision, Inc. Method of packaging and sterilizing a pharmaceutical product
US5323907A (en) 1992-06-23 1994-06-28 Multi-Comp, Inc. Child resistant package assembly for dispensing pharmaceutical medications
US6350458B1 (en) 1998-02-10 2002-02-26 Generex Pharmaceuticals Incorporated Mixed micellar drug deliver system and method of preparation
WO2004089415A2 (en) * 2003-04-11 2004-10-21 Novo Nordisk A/S COMBINATIONS OF AN 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITOR AND A GLUCOCORTICOID RECEPTOR AGONIST
GB0308511D0 (en) * 2003-04-14 2003-05-21 Astex Technology Ltd Pharmaceutical compounds
BRPI0413709A (pt) * 2003-08-21 2006-10-17 Pfizer Prod Inc compostos para o tratamento de distúrbios neurodegenerativos
DE102004009933A1 (de) * 2004-02-26 2005-09-15 Merck Patent Gmbh Verwendung von Thiadiazolharnstoffderivaten
EP2125799A1 (en) 2007-02-28 2009-12-02 Smithkline Beecham Corporation Thiadiazole derivatives, inhibitors of stearoyl-coa desaturase
AU2008345225A1 (en) * 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms
EP2725022B1 (de) * 2008-06-13 2017-03-29 Bayer CropScience AG Neue Amide als Schädlingsbekämpfungsmittel
WO2010073011A2 (en) * 2008-12-23 2010-07-01 Betagenon Ab Compounds useful as medicaments
US8377639B2 (en) * 2009-06-26 2013-02-19 University Of Massachusetts Compounds for modulating RNA binding proteins and uses therefor
RU2601550C2 (ru) * 2010-12-09 2016-11-10 Вокхардт Лимитед Кетолидные соединения
JP6130383B2 (ja) * 2011-09-30 2017-05-17 エンドゥ ファーマシューティカルズ,インコーポレイティド ピリジン誘導体
CN104955332B (zh) * 2013-01-30 2017-03-29 住友化学株式会社 防治节足害虫的方法
WO2015089327A1 (en) * 2013-12-11 2015-06-18 Biogen Idec Ma Inc. Biaryl compounds useful for the treatment of human diseases in oncology, neurology and immunology
CN107001362A (zh) * 2014-10-06 2017-08-01 默克专利有限公司 用作btk抑制剂的杂芳基化合物及其用途
BR112019018230A2 (pt) * 2017-03-02 2020-07-21 Assembly Biosciences, Inc. compostos de sulfamida cíclica e métodos de sua utilização

Similar Documents

Publication Publication Date Title
JP2022554389A5 (cg-RX-API-DMAC7.html)
JP2025148482A5 (cg-RX-API-DMAC7.html)
JP2022554391A5 (cg-RX-API-DMAC7.html)
JP7651101B2 (ja) あざの処置のためのアリールアニリンおよびヘテロアリールアニリン化合物
JP7401482B2 (ja) コロニー刺激因子-1受容体(csf-1r)阻害剤
JP7611278B2 (ja) 金属酵素阻害剤化合物
JP7576799B2 (ja) 皮膚癌の処置のためのアリールアニリンおよびヘテロアリールアニリン化合物
RU2378259C2 (ru) Новые производные аминоиндазолов в качестве лекарственных средств и содержащие их фармацевтические композиции
RU2240322C2 (ru) Производные нафтиридина и содержащая их фармацевтическая композиция
IL263511A (en) 1h-pyrazolo[4,3-b]pyridines as pde1 inhibitors
RU2011121567A (ru) Изоиндолиновые соединения для применения при лечении рака
JP2013530179A (ja) 呼吸器合胞体ウイルス(rsv)感染の処置に使用するためのウレイド−ピラゾール誘導体
IL205501A (en) Preparation of preparations for the treatment of arthritis
JP2017502033A5 (cg-RX-API-DMAC7.html)
WO2012133607A1 (ja) ピラゾール化合物
JP2012531456A5 (cg-RX-API-DMAC7.html)
JP2014526499A5 (cg-RX-API-DMAC7.html)
JP2006507247A5 (cg-RX-API-DMAC7.html)
JP2010500334A5 (cg-RX-API-DMAC7.html)
US20180042922A1 (en) Compositions and methods of treating a neurodegenerative disease
RU2017134110A (ru) Производное пиразола, пригодное в качестве ингибитора рi3к
EP2978761A1 (en) Novel oxazolidinone derivative as cetp inhibitor, its preparation method, and pharmaceutical composition comprising the same
ES2637539T3 (es) Polimorfos de ácido 4-{[4-({[4-(2,2,2-trifluoroetoxi)-1,2-benzoisoxazol-3-il]oxi}metil)piperidin-1-il]metil}-tetrahidro-2H-piran-4-carboxílico como agonistas del receptor de 5-hidroxitriptamina-4 (5-HT4) para el tratamiento de enfermedades gastrointestinales
JP2020511410A5 (cg-RX-API-DMAC7.html)
RU2007118659A (ru) Производное 1, 5-дигетероцикл-1н-триазола